摘要
目的研究2016年四川省恶性肿瘤治疗费用的整体规模、人群分布、机构流向和筹资来源,为合理有效配置卫生资源与制定恶性肿瘤治疗保障政策提供科学依据。方法本研究治疗费用总量信息数据主要来源于2016年《四川省卫生财务年报》、2016年《四川省卫生统计年鉴》等资料;采用多阶段分层整群随机抽样方法,抽取四川省7个市州的样本机构1652家,获得2016年四川省个案样本数据库。本研究以卫生费用核算体系2011(“SHA2011”)为基础,用Stata12.0核算2016年四川省恶性肿瘤的治疗总费用。结果2016年四川省恶性肿瘤治疗总费用为108.34亿元,占肿瘤类疾病治疗总费用的72.83%;治疗费用由高到低前5位分别是支气管和肺部恶性肿瘤、食管恶性肿瘤、胃部恶性肿瘤、肝脏和肝内胆管恶性肿瘤以及乳房恶性肿瘤,其合计值为51.78亿元,占四川省恶性肿瘤总治疗费用47.79%。而69.87%的恶性肿瘤治疗费用发生在45~74岁人群;60岁以上老年人群恶性肿瘤治疗费用占比为52.24%。四川省男性恶性肿瘤总治疗费用为62.20亿元,女性恶性肿瘤总治疗费用为46.14亿元,男性恶性肿瘤总治疗费用高于女性。恶性肿瘤治疗费用筹资来源以公共筹资方案和个人家庭卫生支出为主,分别占49.46%和47.21%。四川省恶性肿瘤治疗费用有67.37%发生在综合医院,而发生在基层医疗机构治疗费用仅占1.93%。结论四川省应当控制恶性肿瘤治疗费用总量,增加预防投入;加强重点人群的筛查力度,抑制重点恶性肿瘤费用增长;强化基层医疗机构在恶性肿瘤防治中的主力作用;优化筹资结构,降低居民个人筹资比重。
Objective To study the scale of curative care expenditure (CCE),population distribution,classification of health care providers and classification of health care financing schemes of malignant tumors in Sichuan Province,and to provide the scientific basis for reasonable and effective distribution of health sources. Methods The data of total treatment costs were from "Sichuan Health Finance Annual Report in 2016","Sichuan Health Statistics Annual Report in 2016". Multistage stratified cluster random sampling method was used to select the data of 1 652 medical and health institutions from 7 cities in Sichuan Province and to obtain finally "Sichuan case database 2016". In this study,on the basis of "A System of Health Accounts 2011 Edition Concise Version (SHA2011)",Stata 12.0 was used to account for the total cost of treatment of malignant tumors in Sichuan in 2016. Results In 2016,the total cost of treatment for malignant tumors in Sichuan Province was 10.834 billion yuan,which was 72.83% of the total cost of treatment for tumor diseases. The malignant tumors order of top five treatment costs was bronchial and pulmonary malignant tumors,esophageal malignant tumors,stomach tumors,malignant tumors of liver and intrahepatic duct,malignant breast tumors,the total value was 5.178 billion yuan,which was 47.79% of the CCE of malignant tumors in Sichuan Province. The 69.87% of cost for treating malignant tumors was used for 45-74 years old group;and 52.24% of cost for treating malignant tumors was used for ≥60 years old group. The total costs for treating male and female malignant tumors in Sichuan Province were 6.22 billion yuan and 4.614 billion yuan ,respectively;the male cost was higher than the female cost. The sources of financing for malignant tumors treatment were mainly the public financing plan (49.46%) and individual household health expenditure (47.21%). The proportions of treating malignant tumors cost used for the general hospitals and the primary medical institutions in Sichuan Province were 67.37% and 1.
作者
刘臻
谭玲
杨练
田兴军
孙群
钟志刚
LIU Zhen;TAN Ling;YANG Lian;TIAN Xing-Jun;SUN Qun;ZHONG Zhi-gang(School of Management,Chengdu University of Traditional Chinese Medicine,Chengdu,Sichuan Province 611137,China)
出处
《中国慢性病预防与控制》
CAS
CSCD
北大核心
2019年第5期321-325,共5页
Chinese Journal of Prevention and Control of Chronic Diseases
基金
国家自然科学基金项目(71603032)
四川省社科重点研究基金项目(2018JDQN003)
关键词
恶性肿瘤
费用
卫生费用核算体系2011
Malignant tumor
Cost
A System of Health Accounts 2011 Edition Concise Version
